An inhibitor of NTCP, Myrcludex B (MyrB), is a myristoylated synthetic lipopeptide of 47 amino acids of the HBV pre-S1 peptide, and it inhibits infection of HBV and TCA uptake. The gene discussed is SLC10A1; the disease is infection.